Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avichai Shimoni

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
Leukemia & Lymphoma|April 7, 2010
Double umbilical cord blood transplant: more than a cell dose?Anfisa Stanevsky, Avichai Shimoni, Ronit Yerushalmi, et al.
Harefuah|January 24, 2014
[Decitabine treatment in myelodysplastic syndromes--results of a compassionate patient program in Israel]Abraham Klepfish, Itay Silbershatz, Gilles Lugassy, et al.
Cornea|November 29, 2012
Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantationYair Ivanir, Avichai Shimoni, Orit Ezra-Nimni, et al.
Blood|January 16, 2010
Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donorsOlga Ostrovsky, Avichai Shimoni, Avital Rand, et al.
Bone Marrow Transplantation|September 3, 2020
Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donorsAvichai Shimoni, Noga Shem-Tov, Ronit Yerushalmi, et al.
Rapid Communications in Mass Spectrometry : RCM|June 27, 2019
A simplified method for detection of N-terminal valine adducts in patients receiving treosulfanGunnar Boysen, Avichai Shimoni, Ivetta Danylesko, et al.
Acta Haematologica|November 16, 2006
Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donorsNinette Amariglio, Jasmine Jacob-Hirsch, Avichai Shimoni, et al.
Leukemia & Lymphoma|December 11, 2007
Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromesAvichai Shimoni, Izhar Hardan, Noga Shem-Tov, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reducedAvichai Shimoni, Moshe Yeshurun, Izhar Hardan, et al.
American Journal of Hematology|January 5, 2017
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donorsRonit Yerushalmi, Noga Shem-Tov, Ivetta Danylesko, et al.
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|April 7, 2010
Double umbilical cord blood transplant: more than a cell dose?Anfisa Stanevsky, Avichai Shimoni, Ronit Yerushalmi, et al.
Harefuah|January 24, 2014
[Decitabine treatment in myelodysplastic syndromes--results of a compassionate patient program in Israel]Abraham Klepfish, Itay Silbershatz, Gilles Lugassy, et al.
Cornea|November 29, 2012
Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantationYair Ivanir, Avichai Shimoni, Orit Ezra-Nimni, et al.
Blood|January 16, 2010
Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donorsOlga Ostrovsky, Avichai Shimoni, Avital Rand, et al.
Bone Marrow Transplantation|September 3, 2020
Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donorsAvichai Shimoni, Noga Shem-Tov, Ronit Yerushalmi, et al.
Rapid Communications in Mass Spectrometry : RCM|June 27, 2019
A simplified method for detection of N-terminal valine adducts in patients receiving treosulfanGunnar Boysen, Avichai Shimoni, Ivetta Danylesko, et al.
Acta Haematologica|November 16, 2006
Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donorsNinette Amariglio, Jasmine Jacob-Hirsch, Avichai Shimoni, et al.
Leukemia & Lymphoma|December 11, 2007
Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromesAvichai Shimoni, Izhar Hardan, Noga Shem-Tov, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reducedAvichai Shimoni, Moshe Yeshurun, Izhar Hardan, et al.
American Journal of Hematology|January 5, 2017
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donorsRonit Yerushalmi, Noga Shem-Tov, Ivetta Danylesko, et al.
Pageof 17